IJCCD Calls for Review Articles on Cancer Care Access and Oncology Delivery
IJCCD invites review articles on cancer care access, delivery challenges, and equity-focused solutions. Submit your manuscript to Binaytaraβs open-access oncology journal with no publication fees.
No submission or publication fees. Rapid 8β10 week timeline. The International Journal of Cancer Care and Delivery (IJCCD), Binaytaraβs flagship open-access journal, is calling for review articles focused on real-world challenges in oncology care delivery. binaytara.org/news/news/ij...
03.03.2026 23:46 β
π 1
π 0
π¬ 0
π 0
Why Indigenous Communities Face Higher Cancer Rates: Biology May Play a Larger Role Than Previously Thought | Cancer News
Indigenous communities face disproportionately high rates of gallbladder and biliary cancers. Emerging research explores genetic risk, biological differences, and why tailored prevention strategiesβ¦
In this powerful analysis, Dr. Jin Mou explores why Indigenous communitiesβincluding American Indian, Alaska Native, and Native Hawaiian/Pacific Islander populationsβcontinue to face disproportionately high rates of lethal cancers like gallbladder and biliary tract cancers:
02.03.2026 18:10 β
π 1
π 0
π¬ 0
π 0
SCHD26 Abstracts Published in IJCCD: Top 6 Oral Presentation Highlights
Over 100 SCHD26 abstracts are now published in IJCCD. Explore highlights from the six top oral presentations addressing cancer health disparities, AI innovation, genomics, and global equity.
Over 100 abstracts from SCHD26 in the International Journal of Cancer Care and Delivery address equity gaps in care. Topics include high-risk HPV in Tanzania, BRCA mutations in Cameroon, mobile mammography in Appalachia, and AI-driven blood cancer screening: binaytara.org/news/news/sc...
01.03.2026 18:10 β
π 0
π 0
π¬ 0
π 0
Join us at the CME/MOC/ACPE-accredited 2026 Oklahoma Thoracic Oncology Conference on March 7: binaytara.org/projects/con... #OKTO26
01.03.2026 01:37 β
π 0
π 0
π¬ 0
π 0
What Is Metastatic Cancer? Understanding When and How Cancer Spreads | Cancer News
Learn what metastatic (stage 4) cancer is, how cancer spreads through the lymphatic system and bloodstream, common metastatic sites, symptoms, diagnosis methods, and current treatment options.
Dr. Chandra Lalita Kakarala breaks down how metastasis occurs, common sites of spread, symptoms to watch for, and how advances in imaging, circulating tumor DNA testing, and modern therapies are improving outcomesβeven in advanced disease.
27.02.2026 18:10 β
π 1
π 0
π¬ 0
π 0
Early-career cancer researchers shouldnβt miss out on an opportunity because of cost. Thatβs why Binaytara has launched the David Aboulafia Merit Award for the Summit on Cancer Health Disparities 2026 (#SCHD26): buff.ly/9TwaLVL
26.02.2026 18:10 β
π 0
π 0
π¬ 0
π 0
The Impact Pitch: Think Shark Tankβbut for cancer health equity.π¦At the Summit on Cancer Health Disparities (#SCHD26), innovators will pitch bold, real-world solutions to close gaps in cancer care, competing for a $25,000 Implementation Science Research Award: buff.ly/Y56SEBU
26.02.2026 01:37 β
π 3
π 0
π¬ 0
π 0
Congratulations to our 2026 #Binaytara Recognition Award winnersβchampions advancing cancer health equity worldwide. πJoin us at #SCHD26 to celebrate their impact. binaytara.org/news/news/bi... #HealthEquity #Awards
25.02.2026 18:18 β
π 1
π 1
π¬ 0
π 0
What Is Metastatic Cancer? Understanding When and How Cancer Spreads | Cancer News
Learn what metastatic (stage 4) cancer is, how cancer spreads through the lymphatic system and bloodstream, common metastatic sites, symptoms, diagnosis methods, and current treatment options.
In this article, Dr. Chandra Kakarala breaks down how metastasis occurs, common sites of spread, symptoms to watch for, and how advances in imaging, circulating tumor DNA testing, and modern therapies are improving outcomesβeven in advanced disease. buff.ly/hj0Yl3U
19.02.2026 00:21 β
π 2
π 0
π¬ 0
π 0
Join us at the CME/MOC/ACPE-accredited Best of Hematology and Breast Cancer 2026, Boise: binaytara.org/projects/con... #HemOnc #CMEConference #Medsky
18.02.2026 18:10 β
π 0
π 0
π¬ 0
π 0
Highlights of ASCO Gastrointestinal Cancer Symposium 2026: From Bench to Bedside | Cancer News
Expert insights from ASCO GI 2026 on pivotal trials shaping care in gastric, colorectal, pancreatic, and liver cancers, including HER2, CLDN18.2, KRAS G12D, MSI-H CRC, and HCC.
From bench to bedside at #ASCO GI 2026 π§¬In this expert recap, Dr. Ibrahim Sahin and Dr. Meghana Singh break down pivotal trials like HERIZON GEA-01, ILLUSTRO, COMMIT II, and BREAKWATER, highlighting where data may soon redefine standards of careβand where caution remains: buff.ly/T7VW6fS #Medsky
16.02.2026 23:17 β
π 0
π 0
π¬ 0
π 0
Join us at the CME/MOC/ACPE-accredited Best of Hematology and Breast Cancer 2026, Boise: binaytara.org/projects/con... #HemOnc #CMEConference #Medsky
16.02.2026 01:37 β
π 0
π 0
π¬ 0
π 0
Join us at the CME/MOC/ACPE-accredited Dogmas & Controversies in Hematologic Malignancies: Los Angeles 2026: binaytara.org/projects/con... #CMEConference #Medsky #HemOnc
13.02.2026 18:10 β
π 0
π 0
π¬ 0
π 0
The Best of Hematology and Breast Cancer 2026 is coming to Coeur d'Alene on March 13-14! Register today: buff.ly/iKyuO7Z
12.02.2026 23:55 β
π 1
π 0
π¬ 0
π 0
Join us at the CME/MOC/ACPE-accredited 2026 #Atlanta Genitourinary Cancers Summit on March 14: buff.ly/J82MZKw
12.02.2026 00:52 β
π 1
π 1
π¬ 0
π 0
Dr. Bart L Scott on Treatment Approaches in Newly Diagnosed Acute Myeloid Leukemia | Cancer News
Expert insights from Dr. Bart L. Scott on first-line therapy for newly diagnosed acute myeloid leukemia, including azacitidineβvenetoclax data, Paradigm trial outcomes, and patient fitnessβ¦
At Best of Hematology & Breast Cancer 2026 in Seattle, Dr. Bart L. Scott (Fred Hutchinson Cancer Center) explored evolving #AML treatment paradigms, highlighting real-world cases and pivotal data from the Paradigm trial: buff.ly/ODOXEjT #CMEConferences #Medsky #Binaytara
10.02.2026 18:10 β
π 1
π 1
π¬ 0
π 0
Liquid Biopsy in Oncology: What Clinicians Are Actually Saying | Cancer News
Oncology experts discuss when to use liquid biopsy versus tissue biopsy, how to interpret ctDNA results, and the clinical challenges of clonal hematopoiesis and MRD testing.
Chaired by Dr. Mamta Parikh, with insights from Drs. Jason N. Rosenbaum, Nicholas Mitsiades, and Ibrahim Halil Sahin, the panel discussion at the Precision Oncology Summit emphasizes why tissue and liquid biopsies are increasingly seen as complementary tools in precision oncology: buff.ly/t4ImY5x
10.02.2026 01:37 β
π 2
π 1
π¬ 0
π 0
Dr. Matthew H. Schwedeβs Insights on Advances in Cellular Therapy | Cancer News
Dr. Matthew H. Schwede reviews major cellular therapy advances, including earlier CAR T use, rapid manufacturing, in vivo CAR T, dual targeting strategies, and new applications in hematologicβ¦
Cellular therapy is moving fastβand Dr. Matthew H. Schwedeβs insights from the Best of Hematology & Breast Cancer 2026 meeting highlight just how transformative the field has become: buff.ly/DpqRkVp #CMEConference #Medsky #Binaytara
09.02.2026 19:34 β
π 0
π 0
π¬ 0
π 0